NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 634785 | 4-Piperidinone, 1-[3-(diethylamino)-1-oxopropyl]-3,5-bis- (phenylmethylene)-, monohydrochloride | 0.0267520285931239 | 0.5943022 |
NSC 645317 | Sanguilutine pseudobase | 0.0267520285931239 | 0.42009318 |
NSC 654379 | ANTINEOPLASTIC-654379 | 0.0267520285931239 | 0.36635324 |
NSC 672131 | Null | 0.0267520285931239 | 0.44578355 |
NSC 674685 | Null | 0.0267520285931239 | 0.32889235 |
NSC 679005 | 2-Butenedioic acid, 2,2'-(2,4-dioxopyrimidine-1,3-diyl)bis-, tetraethyl ester | 0.0267520285931239 | 0.3105439 |
NSC 691844 | Null | 0.0267520285931239 | 0.38263029 |
NSC 702125 | Null | 0.0267520285931239 | 0.056093165 |
NSC 724780 | (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 | 0.0267520285931239 | 0.21762903 |
NSC 736081 | 4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine | 0.0267520285931239 | 0.28011334 |